Rapport Therapeutics Inc. Stock Performance
as on October 18, 2025 at 1:29 am IST
Day's Low
Day's High
$24.32$25.31
2.72%
Downside
1.24%
Upside
52 Week's Low
52 Week's High
$6.43$42.2774.28%
Downside
69.07%
Upside
Rapport Therapeutics Inc. share price movements today
- Previous Close
- $24.87
- Open
- $24.52
- Volume
- 348.4K
- Day's Low - High
- $24.32 - $25.31
- 52 Week Low - High
- $6.43 - $42.27
Rapport Therapeutics Inc. Historical Returns
- 1 Month Return
- -5.44 %
- 3 Month Return
- + 67.59 %
- 1 Year Return
- -11.34 %
- 3 Year Return
- 0 %
- 5 Year Return
- 0 %
Rapport Therapeutics Inc. Stock Fundamentals & Key Indicators
Check Rapport Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.2B
EPS (TTM)
-2.934
Dividend Yield
0.00%
PE Ratio (TTM)
21.48
Industry PE ratio
0PEG Ratio
0Return On Equity TTM
-29.42%
Rapport Therapeutics Inc. Stock Valuation
Track how Rapport Therapeutics Inc. P/E has moved over time to understand its valuation trends.
Rapport Therapeutics Inc. in the last 5 years
Lowest (-8.92x)
September 30, 2025
Industry (0.00x)
October 17, 2025
Today (21.48x)
October 17, 2025
Highest (-3.76x)
March 31, 2025
Today’s Price to Earnings Ratio: 21.48x
Rapport Therapeutics Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Rapport Therapeutics Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $1.2B | NA | 21.48 | 0.00% | |
| BUY | $61.6B | 230.86% | -505.15 | -12.96% | |
| NA | $35.8B | NA | NA | -3.89% | |
| BUY | $104.6B | 87.37% | 29.01 | 31.86% | |
| BUY | $61.1B | -5.1% | 14.53 | 31.37% |
Stock Returns calculator for Rapport Therapeutics Inc. Stock including INR - Dollar returns
The Rapport Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Rapport Therapeutics Inc. investment value today
Current value as on today
₹94,040
Returns
Returns from Rapport Therapeutics Inc. Stock
Dollar Returns*
₹4,914 (+4.91%)
Rapport Therapeutics Inc. Stock’s Investor Sentiment and Interest
Search interest for Rapport Therapeutics Inc. Stock has decreased by -89% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Rapport Therapeutics Inc. Quarterly Profit & Loss
All numbers in Millions USD
Rapport Therapeutics Inc. Annual Profit & Loss
All numbers in Millions USD
Rapport Therapeutics Inc. Quarterly Cash Flow
All numbers in Millions USD
Rapport Therapeutics Inc. Annual Cash Flow
All numbers in Millions USD
Insights on Rapport Therapeutics Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.6% return, outperforming this stock by 66.8%
NEGATIVE IMPACTPrice Dip
In the last 7 days, RAPP stock has moved down by -6.2%
About Rapport Therapeutics Inc.
| Organisation | Rapport Therapeutics Inc. |
| Headquarters | 1325 Boylston Street, Boston, MA, United States, 02215 |
| CEO | Mr. Abraham N. Ceesay M.B.A. |
| E-voting on shares | Click here to vote |
Key Management of Rapport Therapeutics Inc.
Name | Title |
|---|---|
Mr. Abraham N. Ceesay M.B.A. | CEO, President, Treasurer & Director |
Dr. Troy A. Ignelzi | Chief Financial Officer |
Mr. David Bredt M.D., Ph.D. | Founder & Chief Scientific Officer |
Ms. Julie DiCarlo | Head of Communications & Investor Relations |
Dr. Arnold R. Gammaitoni Pharm.D. | Senior Vice President of Medical Affairs |
Dr. Steven M. Paul M.D. | Founder & Independent Chairman |
Ms. Cheryl Gault | Chief Operating Officer |
Ms. Karina Chmielewski | Chief Information Officer & Head of Operations |
Ms. Kathleen A. Wilkinson | Chief People Officer |
Mr. Swamy Yeleswaram Ph.D. | Chief Development Officer |
FAQs
What is Rapport Therapeutics Inc. share price today?
Rapport Therapeutics Inc. share price today is $25 as on at the close of the market. Rapport Therapeutics Inc. share today touched a day high of $25.31 and a low of $24.32.
What is the 52 week high and 52 week low for Rapport Therapeutics Inc. share?
Rapport Therapeutics Inc. share touched a 52 week high of $42.27 on and a 52 week low of $6.43 on . Rapport Therapeutics Inc. stock price today i.e. is closed at $25,which is 40.85% down from its 52 week high and 288.80% up from its 52 week low.
What is Rapport Therapeutics Inc.'s market capitalisation today?
Rapport Therapeutics Inc. market capitalisation is $0.00T as on .
How to invest in Rapport Therapeutics Inc. Stock (RAPP) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Rapport Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Rapport Therapeutics Inc. Shares that will get you 0.0600 shares as per Rapport Therapeutics Inc. share price of $25 per share as on October 18, 2025 at 1:29 am IST.
What is the minimum amount required to buy Rapport Therapeutics Inc. Stock (RAPP) from India?
Indian investors can start investing in Rapport Therapeutics Inc. (RAPP) shares with as little as ₹88.054 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.54 in Rapport Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Rapport Therapeutics Inc. share’s latest price of $25 as on October 18, 2025 at 1:29 am IST, you will get 0.4000 shares of Rapport Therapeutics Inc.. Learn more about
fractional shares .